In the News
Watch or read about MelaFind® related news
-
MELA Sciences, Inc. Rings NASDAQ Opening Bell With Leading Dermatologists To Raise Awareness For Melanoma Detection And Prevention
-
MELA Sciences, Inc. Partners with Dermatologists Nationwide to Promote Skin Cancer Awareness; FREE MelaFind Sessions on May 1
-
MELA Sciences, Inc. Presents New Data That Reinforces The Importance Of MelaFind® As A Diagnostic Tool At AAD Meeting
-
Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination
-
Spotting skin cancer in the Sunshine State just got a little easier. A new 3D tool is helping one local dermatologist screen for the deadliest form of cancer, pain free.
-
MELA Sciences Names Rpr Marketing Communications as its New Agency of Record
-
MelaFind® featured on Fox News as a new medical hope for 2013
-
Dr. Jerome Potozkin shows how he uses MelaFind in his practice
-
MelaFind Listed on Cleveland Clinic’s Top 10 Innovations for 2013 http://www.clevelandclinic.org/INNOVATIONS/SUMMIT/top-ten-innovations/2013/five.html
-
MelaFind Appears on “The Doctors” with Dr. Glynis Ablon of the Ablon Skin Institute
-
MELA Sciences Highlighted in The Wall Street Journal for the 2012 Technology Innovation Award
-
MELA Sciences Announces Second Quarter 2012 Financial Results
-
New device helps detect melanoma early
-
MELA Sciences Announces Positive Results of Impact of MelaFind in German Clinical Study
-
MelaFind Technology Analyzes Deep To Detect Skin Cancer
-
Dr. Doris Day Talks About MelaFind on The View. The segment can be found at the 27:14 mark.
-
New medical device sees under skin
-
American Business Awards Honors MELA Sciences with Two Silver Stevie Awards
-
MelaFind Demonstration on “Good Morning America” with Dr. Doris Day
-
Dr. Doris Day Talks About MelaFind on FOX 5
-
MELA Sciences Announces First Quarter 2012 Financial Results
-
MELA Sciences Named 2012 Bronze Edison Award Winner
-
MELA Sciences to Present at the 37th Annual Deutsche Bank Health Care Conference
-
MELA Sciences to Host Investor Meeting May 7, 2012 in New York
-
MELA to Release First Quarter Financial Results and Host Conference Call
-
Q&A with Dr. Joseph Gulfo, President & CEO of MELA Sciences, Inc. by Gavin Corley
-
MELA Sciences to Present at Upcoming Investor Conference
-
MELA Sciences’ Joe Gulfo on Returning to the Market in the Shadow of the Medical Device Tax
-
MELA Sciences Announces Agreement with Quintiles for Commercial Support Services for MelaFind® in Germany
-
MELA Sciences announces commercial launch of MelaFind®
-
MelaFind® Results Improve Detection of Melanoma, Study Shows.
-
MELA Sciences to Present at Upcoming Investor Conferences
-
MELA Sciences Expands Manufacturing Contract
-
MELA Sciences to Present at 14th Annual Needham Growth Conference
-
MELA Sciences Announces Pricing of Underwritten Public Offering of Common Stock
-
MELA Sciences Announces Additions to Board of Directors
-
MELA Sciences to Present at Upcoming Investor Conferences
-
MELA Sciences Announces FDA Approval for MelaFind®
-
MELA Sciences Receives European Union Approval for MelaFind®
For press inquiries, please contact Rpr Marketing Communications at MelaFindPR@rprmc.com